Fundraising FoxOptMed
New York, US · Founded 2007 · Delaware corporation
Find your way into OptMed
45 people in our graph share verified history with the OptMed team — schools, employers, funds. One of them is your warm intro.
Thomas McMahonunlockedknows Ervin Braun · together at Fairleigh Dickinson University (overlapped)
×11knows the team · via Fairleigh Dickinson University
Founders & leadership
EB
Ervin BraunExecutiveErvin Braun earned a BS from Fairleigh Dickinson University and a DMD from the University of Pennsylvania, followed by fellowship training at Memorial Sloan-Kettering Cancer Center, and has worked as a maxillofacial prosthodontist and in financial investing roles including with Genesis Merchant Partners before becoming CEO of OptMed.
AK
Alain KlapholzExecutive
Board
SS
Steven SandsBoard director
KM
Kevin McKimBoard director
SP
Sanket ParekhBoard director
MS
Martin SandsBoard director
HS
Howard SchrayerBoard director
Reported raises · per SEC filings
Form D private placements$796.8K disclosed across 4 rounds · 2012–2015
▶$200KraisedAug 2015 · 1 investors · BiotechnologyRule 506(b)
▶$200KraisedAug 2015 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kevin McKimDirector
- Martin SandsDirector
- Ervin BraunExecutive Officer, Director
- Steven SandsDirector
- Sanket ParekhDirector
- Alain KlapholzExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $200K
- Proceeds to insiders
- $30K
- First sale
- Jul 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$200KraisedMar 2015 · 3 investors · BiotechnologyRule 506(b)
▶$200KraisedMar 2015 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ervin BraunExecutive Officer, Director
- Steven SandsDirector
- Kevin McKimDirector
- Sanket ParekhDirector
- Martin SandsDirector
- Alain KlapholzExecutive Officer, Director
- Offering amount
- $400K
- Amount sold
- $200K
- Proceeds to insiders
- $35K
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$75KraisedJun 2014 · 1 investors · BiotechnologyRule 506(b)
▶$75KraisedJun 2014 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ervin BraunExecutive Officer, Director
- Martin SandsDirector
- Alain KlapholzExecutive Officer, Director
- Kevin McKimDirector
- Steven SandsDirector
- Offering amount
- $1.5M
- Amount sold
- $75K
- Minimum investment
- $25K
- Proceeds to insiders
- $125K
- First sale
- Jun 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$321.8KraisedFeb 2012 · 4 investors · BiotechnologyRule 506(b)
▶$321.8KraisedFeb 2012 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ervin BraunDirector
- Steven SandsDirector
- Howard SchrayerDirector
- Alain KlapholzExecutive Officer, Director, Promoter
- Martin SandsDirector
- Offering amount
- $2M
- Amount sold
- $321.8K
- Minimum investment
- $10K
- First sale
- Jan 2012
- Incorporated
- Corporation, Delaware, 2007
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has OptMed raised?
- OptMed has disclosed $796.8K raised across 4 rounds.
- Where is OptMed headquartered?
- OptMed is headquartered in New York, US.